BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27581358)

  • 1. Normal hematologic parameters and fetal hemoglobin silencing with heterozygous IKZF1 mutations.
    Abdulhay N; Fiorini C; Kumánovics A; Sun AA; Hansen-Rejali J; Voelkerding KV; Rosenzweig SD; Hill HR; Sankaran VG
    Blood; 2016 Oct; 128(16):2100-2103. PubMed ID: 27581358
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.
    Kuehn HS; Boisson B; Cunningham-Rundles C; Reichenbach J; Stray-Pedersen A; Gelfand EW; Maffucci P; Pierce KR; Abbott JK; Voelkerding KV; South ST; Augustine NH; Bush JS; Dolen WK; Wray BB; Itan Y; Cobat A; Sorte HS; Ganesan S; Prader S; Martins TB; Lawrence MG; Orange JS; Calvo KR; Niemela JE; Casanova JL; Fleisher TA; Hill HR; Kumánovics A; Conley ME; Rosenzweig SD
    N Engl J Med; 2016 Mar; 374(11):1032-1043. PubMed ID: 26981933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Functional Relevance of Variants in the
    Eskandarian Z; Fliegauf M; Bulashevska A; Proietti M; Hague R; Smulski CR; Schubert D; Warnatz K; Grimbacher B
    Front Immunol; 2019; 10():568. PubMed ID: 31057532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual phenotype of heterozygous LOF mutation in IKZF1, with common variable immunodeficiency presenting initially as immune thrombocytopenia: A case report.
    Alzahrani TS; Al-Jabri H; Elhomoudi A
    J Paediatr Child Health; 2022 Dec; 58(12):2308-2311. PubMed ID: 35979904
    [No Abstract]   [Full Text] [Related]  

  • 5. Common Variable Immunodeficiency, Autoimmune Hemolytic Anemia, and Pancytopenia Associated With a Defect in IKAROS.
    Yilmaz E; Kuehn HS; Odakir E; Niemela JE; Ozcan A; Eken A; Rohlfs M; Cansever M; Gok V; Aydin F; Karakukcu M; Hauck F; Klein C; Unal E; Rosenzweig SD; Patiroglu T
    J Pediatr Hematol Oncol; 2021 Apr; 43(3):e351-e357. PubMed ID: 33122583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.
    Boutboul D; Kuehn HS; Van de Wyngaert Z; Niemela JE; Callebaut I; Stoddard J; Lenoir C; Barlogis V; Farnarier C; Vely F; Yoshida N; Kojima S; Kanegane H; Hoshino A; Hauck F; Lhermitte L; Asnafi V; Roehrs P; Chen S; Verbsky JW; Calvo KR; Husami A; Zhang K; Roberts J; Amrol D; Sleaseman J; Hsu AP; Holland SM; Marsh R; Fischer A; Fleisher TA; Picard C; Latour S; Rosenzweig SD
    J Clin Invest; 2018 Jul; 128(7):3071-3087. PubMed ID: 29889099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Point Mutation in IKAROS ZF1 Causes a B Cell Deficiency in Mice.
    Boast B; Miosge LA; Kuehn HS; Cho V; Athanasopoulos V; McNamara HA; Sontani Y; Mei Y; Howard D; Sutton HJ; Omari SA; Yu Z; Nasreen M; Andrews TD; Cockburn IA; Goodnow CC; Rosenzweig SD; Enders A
    J Immunol; 2021 Apr; 206(7):1505-1514. PubMed ID: 33658297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel IKZF1 variant in a family with autosomal dominant CVID: A case for expanding exon coverage in inborn errors of immunity.
    Stojkic I; Prince BT; Kuehn HS; Gil Silva AA; Varga EA; Rosenzweig SD; Ramadesikan S; Supinger R; Marhabaie M; Chang P; Mardis ER; Koboldt DC
    Clin Immunol; 2024 Jul; 264():110244. PubMed ID: 38734037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations.
    Hoshino A; Okada S; Yoshida K; Nishida N; Okuno Y; Ueno H; Yamashita M; Okano T; Tsumura M; Nishimura S; Sakata S; Kobayashi M; Nakamura H; Kamizono J; Mitsui-Sekinaka K; Ichimura T; Ohga S; Nakazawa Y; Takagi M; Imai K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Kojima S; Nonoyama S; Morio T; Kanegane H
    J Allergy Clin Immunol; 2017 Jul; 140(1):223-231. PubMed ID: 27939403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline
    Kuehn HS; Nunes-Santos CJ; Rosenzweig SD
    Expert Rev Clin Immunol; 2021 Apr; 17(4):407-416. PubMed ID: 33691560
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic inactivation of Ikaros is a rare event in human T-ALL.
    Marçais A; Jeannet R; Hernandez L; Soulier J; Sigaux F; Chan S; Kastner P
    Leuk Res; 2010 Apr; 34(4):426-9. PubMed ID: 19796813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous disruption of human SOX6 is insufficient to impair erythropoiesis or silencing of fetal hemoglobin.
    Sankaran VG; Menne J; Heller R
    Blood; 2011 Apr; 117(16):4396-7. PubMed ID: 21511965
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem cell transplant outcomes for patients with dominant negative IKZF1/IKAROS mutations.
    Kellner ES; Krupski C; Kuehn HS; Rosenzweig SD; Yoshida N; Kojima S; Boutboul D; Latour S; Barlogis V; Galambrun C; Stray-Pedersen A; Erichsen HC; Marsh RA
    J Allergy Clin Immunol; 2019 Jul; 144(1):339-342. PubMed ID: 30965037
    [No Abstract]   [Full Text] [Related]  

  • 14. A frequent A gamma-hereditary persistence of fetal hemoglobin in northern Sardinia: its molecular basis and hematologic phenotype in heterozygotes and compound heterozygotes with beta-thalassemia.
    Ottolenghi S; Camaschella C; Comi P; Giglioni B; Longinotti M; Oggiano L; Dore F; Sciarratta G; Ivaldi G; Saglio G
    Hum Genet; 1988 May; 79(1):13-7. PubMed ID: 2452784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of a case with SEA-HPFH deletion thalassemia with whole HBB gene deletion.
    Ly Thi Thanh H; Le Thi Thanh H; Hoang Luong L; Huy Tran T; Liu SC; Truong HN; Ta TV; Bui TH; Tran VK
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):435-441. PubMed ID: 29880180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdeletion of 7p12.1p13, including IKZF1, causes intellectual impairment, overgrowth, and susceptibility to leukaemia.
    Järviaho T; Zachariadis V; Tesi B; Chiang S; Bryceson YT; Möttönen M; Niinimäki R; Bang B; Rahikkala E; Taylan F; Uusimaa J; Harila-Saari A; Nordgren A
    Br J Haematol; 2019 Apr; 185(2):354-357. PubMed ID: 30004112
    [No Abstract]   [Full Text] [Related]  

  • 17. Interpreting elevated fetal hemoglobin in pathology and health at the basic laboratory level: new and known γ- gene mutations associated with hereditary persistence of fetal hemoglobin.
    Amato A; Cappabianca MP; Perri M; Zaghis I; Grisanti P; Ponzini D; Di Biagio P
    Int J Lab Hematol; 2014 Feb; 36(1):13-9. PubMed ID: 23621512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and quantitation of the fetal hemoglobin variant Hb F-Malta-I in adults.
    Altay G; Garver F; Bannister WH; Grech JL; Felice A; Huisman TH
    Biochem Genet; 1977 Oct; 15(9-10):915-23. PubMed ID: 588240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IKZF1 (IKAROS) deletions in B-ALL and its clinical correlation: A prospective study from a tertiary care centre in Northern India.
    Gupta SK; Bakhshi S; Kumar L; Seth R; Kumar R
    Leuk Res; 2016 Feb; 41():7-11. PubMed ID: 26704074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ikaros and erythropoiesis].
    Dijon M; Chabannon C; Tonnelle C
    Med Sci (Paris); 2008 Dec; 24(12):1065-70. PubMed ID: 19116116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.